Dermata Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 12,857 | $138 | 100.00% | 0.83% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 12,000 | $16,200 | 0.00% | 0.77% |
| UBS GROUP AG | 02/14/2025 | 4,142 | $46 | -2.36% | 0.27% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 1,354 | $14 | 100.00% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Dermata Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 6 institutional investors and hedge funds held shares of Dermata Therapeutics, Inc.. The most heavily invested institutionals were:
TWO SIGMA SECURITIES, LLC: 12,857
BOOTHBAY FUND MANAGEMENT, LLC: 12,000
UBS Group AG: 4,142
ARMISTICE CAPITAL, LLC: 1,354
BANK OF AMERICA CORP /DE/: 100
Empery Asset Management, LP: 175,000
1.96% of Dermata Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 205,453 shares in the last 24 months. This purchase volume represents approximately $2,055 in transactions.